SEC Tracker
Get the app

Medicus Pharma MDCX

Medicus Pharma announces potential business combination

Merger communication

Form
425
Filed
Importance
Routine
  1. Potential business combination of Skinject, Inc. with a SPAC
  2. Non-binding letter of intent announced on November 4, 2026
  3. Press releases 99.1 and 99.2 attached
  4. Anticipated completion of the business combination in first half of 2027

Written from the 425 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Medicus Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Champions Oncology CSBR public float $29M, Oct 31, 2025
  2. OnKure Therapeutics OKUR public float $28M, Jun 30, 2025
  3. Rockwell Medical RMTI public float $29M, Jun 30, 2025
  4. Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025
  5. ProMIS Neurosciences PMN public float $30M, Jun 30, 2025